The Market Reports

Index

1 Study Coverage
1.1 Organ Transplant Immunosuppressant Product Introduction
1.2 Market by Type
1.2.1 Global Organ Transplant Immunosuppressant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tacrolimus
1.2.3 Mycophenolate Mofetil
1.2.4 Cyclosporin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Organ Transplant Immunosuppressant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Liver Transplant
1.3.3 Kidney Transplant
1.3.4 Heart Transplant
1.3.5 Other Organ Transplant
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Organ Transplant Immunosuppressant Sales Estimates and Forecasts 2017-2028
2.2 Global Organ Transplant Immunosuppressant Revenue Estimates and Forecasts 2017-2028
2.3 Global Organ Transplant Immunosuppressant Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Organ Transplant Immunosuppressant Sales by Region
2.4.1 Global Organ Transplant Immunosuppressant Sales by Region (2017-2022)
2.4.2 Global Sales Organ Transplant Immunosuppressant by Region (2023-2028)
2.5 Global Organ Transplant Immunosuppressant Revenue by Region
2.5.1 Global Organ Transplant Immunosuppressant Revenue by Region (2017-2022)
2.5.2 Global Organ Transplant Immunosuppressant Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Organ Transplant Immunosuppressant Sales by Manufacturers
3.1.1 Global Top Organ Transplant Immunosuppressant Manufacturers by Sales (2017-2022)
3.1.2 Global Organ Transplant Immunosuppressant Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Organ Transplant Immunosuppressant in 2021
3.2 Global Organ Transplant Immunosuppressant Revenue by Manufacturers
3.2.1 Global Organ Transplant Immunosuppressant Revenue by Manufacturers (2017-2022)
3.2.2 Global Organ Transplant Immunosuppressant Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Organ Transplant Immunosuppressant Revenue in 2021
3.3 Global Organ Transplant Immunosuppressant Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Organ Transplant Immunosuppressant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Organ Transplant Immunosuppressant Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Organ Transplant Immunosuppressant Sales by Type
4.1.1 Global Organ Transplant Immunosuppressant Historical Sales by Type (2017-2022)
4.1.2 Global Organ Transplant Immunosuppressant Forecasted Sales by Type (2023-2028)
4.1.3 Global Organ Transplant Immunosuppressant Sales Market Share by Type (2017-2028)
4.2 Global Organ Transplant Immunosuppressant Revenue by Type
4.2.1 Global Organ Transplant Immunosuppressant Historical Revenue by Type (2017-2022)
4.2.2 Global Organ Transplant Immunosuppressant Forecasted Revenue by Type (2023-2028)
4.2.3 Global Organ Transplant Immunosuppressant Revenue Market Share by Type (2017-2028)
4.3 Global Organ Transplant Immunosuppressant Price by Type
4.3.1 Global Organ Transplant Immunosuppressant Price by Type (2017-2022)
4.3.2 Global Organ Transplant Immunosuppressant Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Organ Transplant Immunosuppressant Sales by Application
5.1.1 Global Organ Transplant Immunosuppressant Historical Sales by Application (2017-2022)
5.1.2 Global Organ Transplant Immunosuppressant Forecasted Sales by Application (2023-2028)
5.1.3 Global Organ Transplant Immunosuppressant Sales Market Share by Application (2017-2028)
5.2 Global Organ Transplant Immunosuppressant Revenue by Application
5.2.1 Global Organ Transplant Immunosuppressant Historical Revenue by Application (2017-2022)
5.2.2 Global Organ Transplant Immunosuppressant Forecasted Revenue by Application (2023-2028)
5.2.3 Global Organ Transplant Immunosuppressant Revenue Market Share by Application (2017-2028)
5.3 Global Organ Transplant Immunosuppressant Price by Application
5.3.1 Global Organ Transplant Immunosuppressant Price by Application (2017-2022)
5.3.2 Global Organ Transplant Immunosuppressant Price Forecast by Application (2023-2028)
6 North America
6.1 North America Organ Transplant Immunosuppressant Market Size by Type
6.1.1 North America Organ Transplant Immunosuppressant Sales by Type (2017-2028)
6.1.2 North America Organ Transplant Immunosuppressant Revenue by Type (2017-2028)
6.2 North America Organ Transplant Immunosuppressant Market Size by Application
6.2.1 North America Organ Transplant Immunosuppressant Sales by Application (2017-2028)
6.2.2 North America Organ Transplant Immunosuppressant Revenue by Application (2017-2028)
6.3 North America Organ Transplant Immunosuppressant Market Size by Country
6.3.1 North America Organ Transplant Immunosuppressant Sales by Country (2017-2028)
6.3.2 North America Organ Transplant Immunosuppressant Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Organ Transplant Immunosuppressant Market Size by Type
7.1.1 Europe Organ Transplant Immunosuppressant Sales by Type (2017-2028)
7.1.2 Europe Organ Transplant Immunosuppressant Revenue by Type (2017-2028)
7.2 Europe Organ Transplant Immunosuppressant Market Size by Application
7.2.1 Europe Organ Transplant Immunosuppressant Sales by Application (2017-2028)
7.2.2 Europe Organ Transplant Immunosuppressant Revenue by Application (2017-2028)
7.3 Europe Organ Transplant Immunosuppressant Market Size by Country
7.3.1 Europe Organ Transplant Immunosuppressant Sales by Country (2017-2028)
7.3.2 Europe Organ Transplant Immunosuppressant Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Organ Transplant Immunosuppressant Market Size by Type
8.1.1 Asia Pacific Organ Transplant Immunosuppressant Sales by Type (2017-2028)
8.1.2 Asia Pacific Organ Transplant Immunosuppressant Revenue by Type (2017-2028)
8.2 Asia Pacific Organ Transplant Immunosuppressant Market Size by Application
8.2.1 Asia Pacific Organ Transplant Immunosuppressant Sales by Application (2017-2028)
8.2.2 Asia Pacific Organ Transplant Immunosuppressant Revenue by Application (2017-2028)
8.3 Asia Pacific Organ Transplant Immunosuppressant Market Size by Region
8.3.1 Asia Pacific Organ Transplant Immunosuppressant Sales by Region (2017-2028)
8.3.2 Asia Pacific Organ Transplant Immunosuppressant Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Organ Transplant Immunosuppressant Market Size by Type
9.1.1 Latin America Organ Transplant Immunosuppressant Sales by Type (2017-2028)
9.1.2 Latin America Organ Transplant Immunosuppressant Revenue by Type (2017-2028)
9.2 Latin America Organ Transplant Immunosuppressant Market Size by Application
9.2.1 Latin America Organ Transplant Immunosuppressant Sales by Application (2017-2028)
9.2.2 Latin America Organ Transplant Immunosuppressant Revenue by Application (2017-2028)
9.3 Latin America Organ Transplant Immunosuppressant Market Size by Country
9.3.1 Latin America Organ Transplant Immunosuppressant Sales by Country (2017-2028)
9.3.2 Latin America Organ Transplant Immunosuppressant Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Organ Transplant Immunosuppressant Market Size by Type
10.1.1 Middle East and Africa Organ Transplant Immunosuppressant Sales by Type (2017-2028)
10.1.2 Middle East and Africa Organ Transplant Immunosuppressant Revenue by Type (2017-2028)
10.2 Middle East and Africa Organ Transplant Immunosuppressant Market Size by Application
10.2.1 Middle East and Africa Organ Transplant Immunosuppressant Sales by Application (2017-2028)
10.2.2 Middle East and Africa Organ Transplant Immunosuppressant Revenue by Application (2017-2028)
10.3 Middle East and Africa Organ Transplant Immunosuppressant Market Size by Country
10.3.1 Middle East and Africa Organ Transplant Immunosuppressant Sales by Country (2017-2028)
10.3.2 Middle East and Africa Organ Transplant Immunosuppressant Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Overview
11.1.3 Roche Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Roche Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Astellas Pharma Inc.
11.2.1 Astellas Pharma Inc. Corporation Information
11.2.2 Astellas Pharma Inc. Overview
11.2.3 Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Astellas Pharma Inc. Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Astellas Pharma Inc. Recent Developments
11.3 Huadong Pharmaceutical
11.3.1 Huadong Pharmaceutical Corporation Information
11.3.2 Huadong Pharmaceutical Overview
11.3.3 Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Huadong Pharmaceutical Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Huadong Pharmaceutical Recent Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Overview
11.4.3 Novartis Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 Catalent Pharma
11.5.1 Catalent Pharma Corporation Information
11.5.2 Catalent Pharma Overview
11.5.3 Catalent Pharma Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Catalent Pharma Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Catalent Pharma Recent Developments
11.6 Cinkate Corporation
11.6.1 Cinkate Corporation Corporation Information
11.6.2 Cinkate Corporation Overview
11.6.3 Cinkate Corporation Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Cinkate Corporation Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cinkate Corporation Recent Developments
11.7 Cilag
11.7.1 Cilag Corporation Information
11.7.2 Cilag Overview
11.7.3 Cilag Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Cilag Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cilag Recent Developments
11.8 Genzyme
11.8.1 Genzyme Corporation Information
11.8.2 Genzyme Overview
11.8.3 Genzyme Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Genzyme Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Genzyme Recent Developments
11.9 Changzhou Pharm
11.9.1 Changzhou Pharm Corporation Information
11.9.2 Changzhou Pharm Overview
11.9.3 Changzhou Pharm Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Changzhou Pharm Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Changzhou Pharm Recent Developments
11.10 North China Pharmaceutical Group Corporation
11.10.1 North China Pharmaceutical Group Corporation Corporation Information
11.10.2 North China Pharmaceutical Group Corporation Overview
11.10.3 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 North China Pharmaceutical Group Corporation Recent Developments
11.11 SL PHARM
11.11.1 SL PHARM Corporation Information
11.11.2 SL PHARM Overview
11.11.3 SL PHARM Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 SL PHARM Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 SL PHARM Recent Developments
11.12 Livzon Pharmaceutical Group Inc.,
11.12.1 Livzon Pharmaceutical Group Inc., Corporation Information
11.12.2 Livzon Pharmaceutical Group Inc., Overview
11.12.3 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Livzon Pharmaceutical Group Inc., Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Organ Transplant Immunosuppressant Industry Chain Analysis
12.2 Organ Transplant Immunosuppressant Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Organ Transplant Immunosuppressant Production Mode & Process
12.4 Organ Transplant Immunosuppressant Sales and Marketing
12.4.1 Organ Transplant Immunosuppressant Sales Channels
12.4.2 Organ Transplant Immunosuppressant Distributors
12.5 Organ Transplant Immunosuppressant Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Organ Transplant Immunosuppressant Industry Trends
13.2 Organ Transplant Immunosuppressant Market Drivers
13.3 Organ Transplant Immunosuppressant Market Challenges
13.4 Organ Transplant Immunosuppressant Market Restraints
14 Key Findings in The Global Organ Transplant Immunosuppressant Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables

List of Tables
Table 1. Global Organ Transplant Immunosuppressant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tacrolimus
Table 3. Major Manufacturers of Mycophenolate Mofetil
Table 4. Major Manufacturers of Cyclosporin
Table 5. Major Manufacturers of Others
Table 6. Global Organ Transplant Immunosuppressant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Organ Transplant Immunosuppressant Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Organ Transplant Immunosuppressant Sales by Region (2017-2022) & (K Units)
Table 9. Global Organ Transplant Immunosuppressant Sales Market Share by Region (2017-2022)
Table 10. Global Organ Transplant Immunosuppressant Sales by Region (2023-2028) & (K Units)
Table 11. Global Organ Transplant Immunosuppressant Sales Market Share by Region (2023-2028)
Table 12. Global Organ Transplant Immunosuppressant Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Organ Transplant Immunosuppressant Revenue Market Share by Region (2017-2022)
Table 14. Global Organ Transplant Immunosuppressant Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Organ Transplant Immunosuppressant Revenue Market Share by Region (2023-2028)
Table 16. Global Organ Transplant Immunosuppressant Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Organ Transplant Immunosuppressant Sales Share by Manufacturers (2017-2022)
Table 18. Global Organ Transplant Immunosuppressant Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Organ Transplant Immunosuppressant Revenue Share by Manufacturers (2017-2022)
Table 20. Organ Transplant Immunosuppressant Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Organ Transplant Immunosuppressant Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Organ Transplant Immunosuppressant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organ Transplant Immunosuppressant as of 2021)
Table 23. Organ Transplant Immunosuppressant Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Organ Transplant Immunosuppressant Product Offered
Table 25. Date of Manufacturers Enter into Organ Transplant Immunosuppressant Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Organ Transplant Immunosuppressant Sales by Type (2017-2022) & (K Units)
Table 28. Global Organ Transplant Immunosuppressant Sales by Type (2023-2028) & (K Units)
Table 29. Global Organ Transplant Immunosuppressant Sales Share by Type (2017-2022)
Table 30. Global Organ Transplant Immunosuppressant Sales Share by Type (2023-2028)
Table 31. Global Organ Transplant Immunosuppressant Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Organ Transplant Immunosuppressant Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Organ Transplant Immunosuppressant Revenue Share by Type (2017-2022)
Table 34. Global Organ Transplant Immunosuppressant Revenue Share by Type (2023-2028)
Table 35. Organ Transplant Immunosuppressant Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Organ Transplant Immunosuppressant Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Organ Transplant Immunosuppressant Sales by Application (2017-2022) & (K Units)
Table 38. Global Organ Transplant Immunosuppressant Sales by Application (2023-2028) & (K Units)
Table 39. Global Organ Transplant Immunosuppressant Sales Share by Application (2017-2022)
Table 40. Global Organ Transplant Immunosuppressant Sales Share by Application (2023-2028)
Table 41. Global Organ Transplant Immunosuppressant Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Organ Transplant Immunosuppressant Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Organ Transplant Immunosuppressant Revenue Share by Application (2017-2022)
Table 44. Global Organ Transplant Immunosuppressant Revenue Share by Application (2023-2028)
Table 45. Organ Transplant Immunosuppressant Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Organ Transplant Immunosuppressant Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Organ Transplant Immunosuppressant Sales by Type (2017-2022) & (K Units)
Table 48. North America Organ Transplant Immunosuppressant Sales by Type (2023-2028) & (K Units)
Table 49. North America Organ Transplant Immunosuppressant Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Organ Transplant Immunosuppressant Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Organ Transplant Immunosuppressant Sales by Application (2017-2022) & (K Units)
Table 52. North America Organ Transplant Immunosuppressant Sales by Application (2023-2028) & (K Units)
Table 53. North America Organ Transplant Immunosuppressant Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Organ Transplant Immunosuppressant Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Organ Transplant Immunosuppressant Sales by Country (2017-2022) & (K Units)
Table 56. North America Organ Transplant Immunosuppressant Sales by Country (2023-2028) & (K Units)
Table 57. North America Organ Transplant Immunosuppressant Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Organ Transplant Immunosuppressant Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Organ Transplant Immunosuppressant Sales by Type (2017-2022) & (K Units)
Table 60. Europe Organ Transplant Immunosuppressant Sales by Type (2023-2028) & (K Units)
Table 61. Europe Organ Transplant Immunosuppressant Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Organ Transplant Immunosuppressant Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Organ Transplant Immunosuppressant Sales by Application (2017-2022) & (K Units)
Table 64. Europe Organ Transplant Immunosuppressant Sales by Application (2023-2028) & (K Units)
Table 65. Europe Organ Transplant Immunosuppressant Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Organ Transplant Immunosuppressant Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Organ Transplant Immunosuppressant Sales by Country (2017-2022) & (K Units)
Table 68. Europe Organ Transplant Immunosuppressant Sales by Country (2023-2028) & (K Units)
Table 69. Europe Organ Transplant Immunosuppressant Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Organ Transplant Immunosuppressant Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Organ Transplant Immunosuppressant Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Organ Transplant Immunosuppressant Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Organ Transplant Immunosuppressant Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Organ Transplant Immunosuppressant Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Organ Transplant Immunosuppressant Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Organ Transplant Immunosuppressant Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Organ Transplant Immunosuppressant Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Organ Transplant Immunosuppressant Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Organ Transplant Immunosuppressant Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Organ Transplant Immunosuppressant Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Organ Transplant Immunosuppressant Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Organ Transplant Immunosuppressant Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Organ Transplant Immunosuppressant Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Organ Transplant Immunosuppressant Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Organ Transplant Immunosuppressant Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Organ Transplant Immunosuppressant Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Organ Transplant Immunosuppressant Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Organ Transplant Immunosuppressant Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Organ Transplant Immunosuppressant Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Organ Transplant Immunosuppressant Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Organ Transplant Immunosuppressant Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Organ Transplant Immunosuppressant Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Organ Transplant Immunosuppressant Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Organ Transplant Immunosuppressant Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Organ Transplant Immunosuppressant Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Organ Transplant Immunosuppressant Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Organ Transplant Immunosuppressant Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Organ Transplant Immunosuppressant Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Organ Transplant Immunosuppressant Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Organ Transplant Immunosuppressant Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Organ Transplant Immunosuppressant Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Organ Transplant Immunosuppressant Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Organ Transplant Immunosuppressant Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Organ Transplant Immunosuppressant Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Organ Transplant Immunosuppressant Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Organ Transplant Immunosuppressant Revenue by Country (2023-2028) & (US$ Million)
Table 107. Roche Corporation Information
Table 108. Roche Description and Major Businesses
Table 109. Roche Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Roche Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Roche Recent Developments
Table 112. Astellas Pharma Inc. Corporation Information
Table 113. Astellas Pharma Inc. Description and Major Businesses
Table 114. Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Astellas Pharma Inc. Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Astellas Pharma Inc. Recent Developments
Table 117. Huadong Pharmaceutical Corporation Information
Table 118. Huadong Pharmaceutical Description and Major Businesses
Table 119. Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Huadong Pharmaceutical Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Huadong Pharmaceutical Recent Developments
Table 122. Novartis Corporation Information
Table 123. Novartis Description and Major Businesses
Table 124. Novartis Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Novartis Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Novartis Recent Developments
Table 127. Catalent Pharma Corporation Information
Table 128. Catalent Pharma Description and Major Businesses
Table 129. Catalent Pharma Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Catalent Pharma Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Catalent Pharma Recent Developments
Table 132. Cinkate Corporation Corporation Information
Table 133. Cinkate Corporation Description and Major Businesses
Table 134. Cinkate Corporation Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Cinkate Corporation Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Cinkate Corporation Recent Developments
Table 137. Cilag Corporation Information
Table 138. Cilag Description and Major Businesses
Table 139. Cilag Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Cilag Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Cilag Recent Developments
Table 142. Genzyme Corporation Information
Table 143. Genzyme Description and Major Businesses
Table 144. Genzyme Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Genzyme Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Genzyme Recent Developments
Table 147. Changzhou Pharm Corporation Information
Table 148. Changzhou Pharm Description and Major Businesses
Table 149. Changzhou Pharm Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Changzhou Pharm Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Changzhou Pharm Recent Developments
Table 152. North China Pharmaceutical Group Corporation Corporation Information
Table 153. North China Pharmaceutical Group Corporation Description and Major Businesses
Table 154. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. North China Pharmaceutical Group Corporation Recent Developments
Table 157. SL PHARM Corporation Information
Table 158. SL PHARM Description and Major Businesses
Table 159. SL PHARM Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. SL PHARM Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. SL PHARM Recent Developments
Table 162. Livzon Pharmaceutical Group Inc., Corporation Information
Table 163. Livzon Pharmaceutical Group Inc., Description and Major Businesses
Table 164. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 165. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Livzon Pharmaceutical Group Inc., Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Organ Transplant Immunosuppressant Distributors List
Table 170. Organ Transplant Immunosuppressant Customers List
Table 171. Organ Transplant Immunosuppressant Market Trends
Table 172. Organ Transplant Immunosuppressant Market Drivers
Table 173. Organ Transplant Immunosuppressant Market Challenges
Table 174. Organ Transplant Immunosuppressant Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Organ Transplant Immunosuppressant Product Picture
Figure 3. Global Organ Transplant Immunosuppressant Market Share by Type in 2021 & 2028
Figure 3. Tacrolimus Product Picture
Figure 4. Mycophenolate Mofetil Product Picture
Figure 5. Cyclosporin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Organ Transplant Immunosuppressant Market Share by Application in 2021 & 2028
Figure 8. Liver Transplant
Figure 9. Kidney Transplant
Figure 10. Heart Transplant
Figure 11. Other Organ Transplant
Figure 12. Organ Transplant Immunosuppressant Report Years Considered
Figure 13. Global Organ Transplant Immunosuppressant Sales 2017-2028 (K Units)
Figure 14. Global Organ Transplant Immunosuppressant Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Organ Transplant Immunosuppressant Revenue 2017-2028 (US$ Million)
Figure 16. Global Organ Transplant Immunosuppressant Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Organ Transplant Immunosuppressant Sales Market Share by Region (2017-2022)
Figure 18. Global Organ Transplant Immunosuppressant Sales Market Share by Region (2023-2028)
Figure 19. North America Organ Transplant Immunosuppressant Sales YoY (2017-2028) & (K Units)
Figure 20. North America Organ Transplant Immunosuppressant Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Organ Transplant Immunosuppressant Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Organ Transplant Immunosuppressant Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Organ Transplant Immunosuppressant Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Organ Transplant Immunosuppressant Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Organ Transplant Immunosuppressant Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Organ Transplant Immunosuppressant Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Organ Transplant Immunosuppressant Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Organ Transplant Immunosuppressant Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Organ Transplant Immunosuppressant Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Organ Transplant Immunosuppressant in the World: Market Share by Organ Transplant Immunosuppressant Revenue in 2021
Figure 31. Global Organ Transplant Immunosuppressant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Organ Transplant Immunosuppressant Sales Market Share by Type (2017-2028)
Figure 33. Global Organ Transplant Immunosuppressant Revenue Market Share by Type (2017-2028)
Figure 34. Global Organ Transplant Immunosuppressant Sales Market Share by Application (2017-2028)
Figure 35. Global Organ Transplant Immunosuppressant Revenue Market Share by Application (2017-2028)
Figure 36. North America Organ Transplant Immunosuppressant Sales Market Share by Type (2017-2028)
Figure 37. North America Organ Transplant Immunosuppressant Revenue Market Share by Type (2017-2028)
Figure 38. North America Organ Transplant Immunosuppressant Sales Market Share by Application (2017-2028)
Figure 39. North America Organ Transplant Immunosuppressant Revenue Market Share by Application (2017-2028)
Figure 40. North America Organ Transplant Immunosuppressant Sales Share by Country (2017-2028)
Figure 41. North America Organ Transplant Immunosuppressant Revenue Share by Country (2017-2028)
Figure 42. U.S. Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Organ Transplant Immunosuppressant Sales Market Share by Type (2017-2028)
Figure 45. Europe Organ Transplant Immunosuppressant Revenue Market Share by Type (2017-2028)
Figure 46. Europe Organ Transplant Immunosuppressant Sales Market Share by Application (2017-2028)
Figure 47. Europe Organ Transplant Immunosuppressant Revenue Market Share by Application (2017-2028)
Figure 48. Europe Organ Transplant Immunosuppressant Sales Share by Country (2017-2028)
Figure 49. Europe Organ Transplant Immunosuppressant Revenue Share by Country (2017-2028)
Figure 50. Germany Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 51. France Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Organ Transplant Immunosuppressant Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Organ Transplant Immunosuppressant Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Organ Transplant Immunosuppressant Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Organ Transplant Immunosuppressant Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Organ Transplant Immunosuppressant Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Organ Transplant Immunosuppressant Revenue Share by Region (2017-2028)
Figure 61. China Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 64. India Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Organ Transplant Immunosuppressant Sales Market Share by Type (2017-2028)
Figure 72. Latin America Organ Transplant Immunosuppressant Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Organ Transplant Immunosuppressant Sales Market Share by Application (2017-2028)
Figure 74. Latin America Organ Transplant Immunosuppressant Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Organ Transplant Immunosuppressant Sales Share by Country (2017-2028)
Figure 76. Latin America Organ Transplant Immunosuppressant Revenue Share by Country (2017-2028)
Figure 77. Mexico Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Organ Transplant Immunosuppressant Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Organ Transplant Immunosuppressant Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Organ Transplant Immunosuppressant Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Organ Transplant Immunosuppressant Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Organ Transplant Immunosuppressant Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Organ Transplant Immunosuppressant Revenue Share by Country (2017-2028)
Figure 86. Turkey Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Organ Transplant Immunosuppressant Revenue (2017-2028) & (US$ Million)
Figure 89. Organ Transplant Immunosuppressant Value Chain
Figure 90. Organ Transplant Immunosuppressant Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed